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INSIGHTS FROM MODEL SYSTEMS
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There have been both genetic and biochemical advances
in the understanding of inherited neurodegenerative dis-
eases, such as Huntington disease (HD) and Friedreich
ataxia (FA). In FA, these advances have come from the
following two approaches: the mapping of the disease
gene in humans, and work with a distantly relatedmodel
organism, Saccharomyces cerevisiae. These two ap-
proaches converged, with the study of the human gene
leading to the yeast homologue and the study of the yeast
mutant phenotypes leading to the human homologue
and its associated disease.
FA has an estimated prevalence of 1/50,000 in Euro-
pean populations, making it the most common inherited
ataxia. The neurologic symptoms, which start during
adolescence, include gait and limb ataxia, lower limb
areflexia and pyramidal weakness, loss of propriocep-
tion, and dysarthria.Most patients develop hypertrophic
cardiomyopathy and skeletal abnormalities, and some
become diabetic (Durr et al. 1996). These symptoms
progress with age, such that most patients become
wheelchair-bound by their late twenties and die by their
mid-thirties—most commonly of congestive heart
failure.
Genetically, FA belongs to a class of neurodegenerative
disorders in which the underlying gene, FRDA1, carries
an unstable trinucleotide-repeat sequence. At least eight
other members of this class have been identified, in-
cluding HD and many types of spinocerebellar ataxia.
However, key genetic features separate FA from the other
trinucleotide-repeat disorders. First, the sequence of the
trinucleotide repeat in the FRDA1 gene is GAA (Cam-
puzano et al. 1996), whereas a CAG repeat occurs in
the other trinucleotide-associated ataxias, and other re-
peats (CTG or CGG) are seen in other trinucleotide dis-
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eases. Second, the GAA repeat of FRDA1 is located in
the first intron and is therefore noncoding, whereas the
CAG repeat in HD and the spinocerebellar ataxias al-
ways occurs within an exon and encodes glutamine
(Campuzano et al. 1996). The third difference is that FA
is inherited in a recessive manner, and multiple lines of
evidence suggest that loss of function leads to the disease.
In contrast, in the other trinucleotide-repeat disorders,
whether the repeat occurs in an expressedDNAsequence
(Paulson 1999 [in this issue]) or in a 3′ untranslated
sequence (Timchenko 1999 [in this issue]), the mutation
is inherited in a dominant manner, and it is a gain of
function of the affected protein or RNA that perturbs
cell physiology.
The severity of the disease correlates with decreased
FRDA1 expression and with the length of the hyper-
expansive repeat. Normally, this gene, which encodes
the protein frataxin, contains !39 GAA repeats, but in
patients with FA, this locus contains 66–1,700 repeat
units. This hyperexpansion results in marked decreases
in frataxin mRNA levels, thought to result from the
formation of an unusual non-bDNA structure inhibiting
transcription (Bidichandani et al. 1998; Sinden 1999 [in
this issue]). More than 95% of patients with FA are
homozygous for the GAA hyperexpansion, although the
alleles are polymorphic in the number of GAA repeats.
Studies have shown a correlation between the length of
the GAA expansion on the smaller allele and severity of
disease (Durr et al. 1996). An inverse correlation be-
tween GAA expansion size and frataxin protein levels
has been observed in lymphoblast cell lines from patients
with FA (Campuzano et al. 1996). Together, these find-
ings suggest that lack of frataxin protein in critical tis-
sues leads to FA. The remaining 5% of patients with FA
are compound heterozygotes for the GAA expansion on
one allele and carry point mutations within FRDA1 on
the other allele.
The most common disease-causing point mutation in
frataxin is I154F (numbering based on the initiator me-
thionine of the predicted open reading frame [ORF]),
prevalent in some southern Italian families. Those in-
dividuals carrying this missense mutation on one allele,
together with the hyperexpansion on the other allele, are
indistinguishable in disease severity when compared
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Ironclad Evidence
In yeast cells, as in human cells, nuclear and mitochondrial
genes are required, for mitochondria to function. Yeast mtDNA
encode eight polypeptides (compared with 13 open reading
frames in human mtDNA), plus ribosomal and transfer RNA.
The major mitochondrial functions, oxidative phosphorylation
and oxidative metabolism of fatty acids, clearly are essential in
metazoans, but yeast cells completely lacking mtDNA can be
grown indefinitely, so long as fermentable carbon sources, such
as glucose, are provided in their medium. For this reason, nu-
clear or mitochondrial mutations that affect oxidative phos-
phorylation can readily be identified as mutant yeast cells that
fail to grow on a nonfermentable carbon source, such as glyc-
erol. Such yeast strains are termed “pet” mutants, because their
growth, even on glucose, is slow, leading to small (“petite”)
colonies. When pet mutants arise from mutations in mtDNA,
they may be described as either ror ro, depending on whether
the mtDNA has undergone large deletions or has been lost from
the cell entirely. The figure below depicts the strategy we applied
to show that one pet yeast strain, mutant for a nucleus-encoded
gene, Yfh1, is ror ro as a consequence of this mutation. Yfh1
encodes a homologue of the human frataxin protein, which is
implicated in Friedreich ataxia. We crossed the yfh1 mutant
with a ro strain, in which the nuclear genome was wild type.
The resulting diploid yeast cell, like the yfh1  parental strain,
could not grow on the glycerol carbon source, indicating that
mtDNA in yfh1 cannot restore mitochondrial function, even
when the Yfh1p protein is available from the other parental
strain.
A link between iron and mtDNA damage was suggested,
from the independent cloning of YFH1 as a high-copy sup-
pressor of a mutant yeast that was defective in its use of in-
tracellular iron. Loss of YFH1 function leads to mtDNA dam-
age and to mitochondrial accumulation of iron. Another
relevant gene, SSQ1,was identified in a screen for yeast mutants
exhibiting altered iron homeostasis. Like yfh1 mutants, ssq1
cells accumulate iron in mitochondria and sustain mitochon-
drial DNA damage. Because SSQ1 encodes a putative mito-
chondrial Hsp70, we looked for evidence that chaperone defects
affect Yfh1p maturation, and we observed that Yfh1p pro-
cessing in mitochondria was compromised in ssq1 yeast. We
suggest that the human frataxin protein plays a similar role in
intracellular iron trafficking and that other human genes, anal-
ogous to SSQ1, may be relevant to the pathogenesis of certain
other disorders related to Friedreich ataxia.
with homozygous relatives who carry the GAA triplet
expansion on both alleles (Campuzano et al. 1996). An-
other missense mutation in frataxin, G130V, com-
pounded with a hyperexpansive allele, is associated with
a milder and more slowly progressive disease course (Bi-
dichandani et al. 1997). Of note is that disease-causing
point mutations in frataxin occur in residues conserved
with the homologous yeast protein. The precise bio-
chemical function that is disrupted is unknown, but it
may relate to iron metabolism.
Phenotypic variants of FA, which nonetheless are
caused by mutations at the FRDA1 locus, include FA
with retained lower limb reflexes, late-onset FA, and the
more slowly progressing Acadian FA variant (Palau et
al. 1995). These less-severe variants of FA often occur
in individuals carrying intermediate lengths of the GAA
repeat. Because of this proportionate loss of expression
of FRDA1 as the GAA trinucleotide expands, the disease
mechanism in FA is more analogous to that of fragile
X–linked mental retardation (FXMR) than to the other
repeat-associated ataxias. However, the analogy to
FXMR is also imperfect, because, in that disorder, loss
of gene expression is associated with CpG methylation
in long CGG tracts in the 5′ untranslated region of the
first exon of FMR1. Such a mechanism is incompatible
with the structure of the intronic GAA repeats in
FRDA1.
The Yeast Connection
At the time of its identification, the deduced
210–amino acid sequence of frataxin revealed no clue
to its function, other than the presence of an N-terminal
sequence that suggested mitochondrial localization
(Campuzano et al. 1996). The frataxin ORF is homol-
ogous to ORFs from Caenorhabditis elegans and S. cer-
evisiae. A homologue is also present in a gram-negative
bacterial species, whose genomic structure suggests that
it is related to the predecessors of eukaryotic mitochon-
dria. Thus, the frataxin gene may have existed first
within the ancestral mtDNA of eukaryotes and then
moved to the nuclear genome at some time early in eu-
karyotic evolution.
The connection of FA with mitochondrial function
was significantly strengthened by the study of the yeast
frataxin homologue encoded by YFH1. The encoded
protein was localized to yeast mitochondria by immu-
nofluorescence microscopy. Furthermore, disruption of
this gene caused the yeast to be unable to grow on non-
fermentable carbon sources (e.g., glycerol plus ethanol)
and to grow poorly on fermentable carbon sources (e.g.,
glucose). The yfh1mutant strains thus display a “petite”
phenotype (see sidebar) and are unable to carry out nor-
mal oxidative phosphorylation (Babcock et al. 1997;
Foury and Cazzalini 1997; Koutnikova et al. 1997; Wil-
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son and Roof 1997), at least in part because of mtDNA
damage.
A major insight into FA came when seemingly unre-
lated studies on metal metabolism in yeast suggested the
involvement of iron. Iron transport into yeast is medi-
ated by ferric reductases of the plasma membrane (Fre1p
and Fre2p), which reduce iron to its ferrous form before
it is brought into the cell through Ftr1p, an iron per-
mease, and its associated multicopper oxidase, Fet3p
(Askwith and Kaplan 1998). All of these genes are under
the control of Aft1p, an iron-sensitive transcriptional
factor. When yeast lack iron, Aft1p activates transcrip-
tion of the iron-uptake components, and conversely,
when iron is plentiful, Aft1p-dependent transcription
ceases. Although this cellular import pathway is well
understood, little is known about the trafficking of iron
once it enters the cell. Therefore, Li and Kaplan (1996)
sought mutants that were defective in intracellular iron
usage. YFH1 was identified as a high copy-number sup-
pressor of one such mutant, thereby linking the yeast
frataxin homologue to iron (Babcock et al. 1997).
Cells lacking YFH1 exhibit constitutive activity of the
high-affinity iron uptake system. Cytosolic iron is di-
minished in yfh1 cells (Knight et al. 1998), whereas mi-
tochondrial iron is 10-fold higher (Babcock et al.
1997; Foury and Cazzalini 1997). This suggests that lack
of Yfh1p causes iron accumulation in mitochondria and
breakdown of cellular iron homeostasis. The exact cause
of the mitochondrial iron accumulation is not known;
however, a role for Yfh1p in efflux of iron from the
mitochondria has been suggested (Askwith and Kaplan
1998).
Iron and FA
With new insight gained from yeast genetic studies
that suggest FA may be associated with altered cellular
iron distrubution, it is possible, in hindsight, to find sup-
portive evidence from earlier studies in the biochemical
and clinical literature. One such study evaluated the fate
of radioactive iron citrate administered to patients with
FA, compared with individuals with Hallervorden-Spatz
disease (Szanto and Gallyas 1966). The patients with FA
exhibited more-rapid turnover of iron in plasma and in
red blood cells, suggesting a decrease in red-cell survival.
Plasma iron concentration, plasma iron binding capac-
ity, and urinary iron were not affected. Measurements
of levels of hemoglobin, bilirubin, lactate dehydroge-
nase, and reticulocyte counts were not reported. A sub-
sequent study has confirmed that patients with FA ex-
hibit normal levels of serum iron and ferritin (Wilson et
al. 1998). However, these measurements reflect red-cell
iron metabolism, which may be regulated by specifically
dedicated feedback loops, as compared with other
tissues.
Despite the ubiquitous expression of frataxin in all
tissues, the primary effects of FA are seen in the central
nervous system, specifically in large sensory neurons and
dorsal root ganglia. The heart is also targeted, and the
resulting cardiomyopathy limits life expectancy (Kout-
nikova et al. 1997). The reasons for this pattern of tissue
sensitivity are not known, although they may relate to
the metabolic rate and abundance of mitochondria in
these tissues (Koutnikova et al. 1997). Postmortem ex-
amination of hearts from patients with FA have shown
zones of cardiac muscle degeneration, with many iron
deposits within myocardial fibers (Lamarche et al.
1980). Electron microscopy of myocardial fibers showed
electron-dense deposits, surrounded by membranes and
associated with damaged mitochondria. These deposits
were termed “lipofuscin”—an ill-defined autofluores-
cent aggregate, containing polyunsaturated lipids and
proteins. Although these deposits were not analyzed for
iron, it is tempting to speculate that it might be present.
Iron is a cofactor for numerous heme and Fe-S pro-
teins of mitochondria. In the electron transport chains
of yeast and mammals, for example, complex II (suc-
cinate: ubiquinone oxidoreductase) contains Fe-S clus-
ters as prosthetic groups, whereas complex III (bc1 com-
plex) contains both Fe-S in the Rieske iron-sulfur protein
and heme in the form of cytochromes b and c1, and
complex IV (cytochrome c oxidase) contains heme as
cytochromes a and a3. Also present in mitochondria is
aconitase, an Fe-S enzyme of the tricarboxylic acid cycle.
In endomyocardial biopsied tissue from two patients
with FA, activity levels of complexes II and III were
found to be in the low to normal range. Of the enzymes
analyzed, aconitase activity exhibited amarked decrease,
relative to that of normal controls. Low enzyme activities
were noted only in the diseased heart tissue and not in
the unaffected tissues that included skeletal muscle, lym-
phocytes, or skin fibroblasts (Rotig et al. 1997). Simi-
larly, in the yfh1 yeast mutants, the activities of com-
plexes II, III, and IV, as well as aconitase, were reduced.
Overall, the yfh1 yeast mutant and disease tissue from
patients with FA exhibit extraordinary similarities. Iron
accumulates in mitochondria (in the yeast mutant and
perhaps in the human disease tissue) in vast excess, and
yet, paradoxically, iron proteins are deficient. The effects
are more severe in the yeast than in the FA tissue, perhaps
reflecting the difference between reduced expression of
FRDA1 in humans versus YFH1 deletion in yeast.
The Importance of Mitochondrial Chaperones for
Iron Homeostasis
In a screen for mutations affecting iron metabolism
in yeast, another mutant that accumulates iron in the
mitochondria was isolated (Knight et al. 1998). The de-
fect in this case was in a nuclear gene encoding a mi-
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tochondrial heat-shock protein 70 (Hsp70). In yeast,
there are two mitochondrial Hsp70 (homologous to
DnaK in bacteria), encoded by the genes SSC1 and
SSQ1. These proteins belong to the class of Hsp70 chap-
erones that facilitate the importing, processing, and fold-
ing of proteins in various organelles. Most proteins des-
tined for the mitochondria are encoded in the nucleus
and translated on cytoplasmic ribosomes. Hydrophobic
regions of proteins interact with Ssc1p in the mitochon-
drial matrix during import (Kang et al. 1990). This chap-
erone acts in association with at least 2 other proteins,
Mdj1p (a homologue of the bacterial protein DnaJ) and
Mge1p (a GrpE homologue). These three proteins use
energy from ATP hydrolysis, to ensure that the incoming
protein folds correctly (Horst et al. 1997). For a subset
of proteins, a second maturation system is required,
which consists of Hsp60 (GroEL) and Hsp10 (GroES).
This complex traps the nonfolded protein and allows
the protein to fold into its native form. The protein is
then released, after ATP hydrolysis. The released protein
may achieve its native conformation immediately, or it
may require additional rounds of interaction with the
chaperone before reaching its final state (Martin 1997).
The Hsp70 gene, SSC1, is essential and abundantly
expressed in yeast. The second mitochondrial Hsp70,
SSQ1, originally was cloned as a homologue of SSC1
(Schilke et al. 1996). SSQ1 was found to be nonessential
and expressed at low levels, when compared with SSC1.
It was also found to play a role in maintaining mtDNA
(Schilke et al. 1996). SSQ1 was independently cloned
from a screen of yeast mutants with defective cellular
iron homeostasis (Knight et al. 1998). Like yfh1 mu-
tants, ssq1 cells exhibit increased cellular iron uptake,
iron diversion to the mitochondria, and accumulation
of mtDNA damage (Knight et al. 1998). This phenotypic
similarity between yfh1 and ssq1 mutations prompted
investigations to determine whether Ssq1p is required
for Yfh1p import and processing in mitochondria.
In wild-type cells, Yfh1p is imported as a preprotein
and is subjected to two sequential processing cleavages
at the N-terminus (Knight et al. 1998). The first cleavage
removes ∼2 kDa, and the second cleavage removes an-
other 4 kDa. In the ssq1 mutant, the second cleavage is
impaired kinetically. The mechanism by which Ssq1p
participates in the second processing step of Yfh1p is
not known, but it may hold Yfh1p in a conformation
that favors processing. Alternatively, Ssq1p may be re-
quired for the correct folding of Yfh1p, for its insertion
into a multiprotein complex.
SSQ1 appears to be involved in the processing of
Yfh1p within mitochondria. By contrast, import and
proteolytic processing of Rieske iron-sulfur protein, cy-
tochrome b2, and cytochrome c1, all components of
Complex III, do not require Ssq1p. The import and pro-
cessing of a noniron protein, prePut2, an enzyme of pro-
line biosynthesis, also proceeds normally in the ssq1mu-
tant strain (Schilke et al. 1996; Knight et al. 1998).
However, it would be surprising that a specific chaperone
is required for the processing of a single protein, and so
it seems likely that other substrates for the Ssq1p chap-
erone will be identified.
Mechanisms of Cellular Toxicity in FA
The biochemical data from the yeast mutants suggest
several mechanisms by which cellular damage might oc-
cur in patients with FA. According to one scenario, the
accumulation of large amounts of iron within mito-
chondria leads to production of reactive oxygen species
via the iron-catalyzed Fenton reaction (Babcock et al.
1997; Foury and Cazzalini 1997). The highly reactive
hydroxyl radicals produced by this chemistry then react
and damage any molecules in their vicinity, including
DNA, proteins, and lipids. Evidence for this hypothesis
comes from the observed hypersensitivity of yfh1 cells
to environmental oxidants. The situation is likely to be
much more complex, however. Although the mitochon-
dria of yfh1 and ssq1 yeast mutants are full of iron,
mitochondrial iron proteins lack activity. The iron,
though plentiful, appears to be biologically unavailable,
either because it cannot be incorporated into heme or
iron-sulfur clusters or because the iron proteins are de-
stabilized. The resulting iron protein deficiency likely
results in problems with the numerous functions sub-
served by these proteins, such as oxidative phosphory-
lation and amino acid metabolism.
These two mechanisms of cellular toxicity—oxidative
stress and iron protein deficiency—are not independent
of each other. Iron-sulfur proteins, such as aconitase, are
known to be exquisitely sensitive to superoxide, which
is capable of attacking and destroying iron-sulfur clus-
ters. Thus, oxidant stress might directly cause iron-sulfur
protein deficiency. The release of the protein-bound iron
could in turn exacerbate the iron overload already ex-
isting. An important feature of the yeast mutants exhib-
iting iron overload and iron protein deficiency is that
these effects occur primarily within mitochondria. Cy-
tosolic iron levels remain to be relatively decreased. This
intracellular compartmentalization of iron may be crit-
ical in explaining the mechanisms and targets of cell
damage. Interestingly, yeast with mutations in the SSQ1
gene were also isolated as suppressors of sod1 mutant
yeast (Strain et al. 1998). SOD1, encoding the cytosolic
copper-zinc superoxide dismutase, is responsible for pro-
tection of the cytosolic compartment from excess su-
peroxide by dismutation of superoxide to hydrogen per-
oxide and oxygen. This observation suggests that lack
of function of the mitochondrial chaperone, SSQ1, par-
tially relieves cytosolic oxidative stress.
Other mechanisms of cellular toxicity, suggested by
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Figure 1 Electron micrographs of mutant and wild-type yeast.
A, Wild-type yeast. B, The ssq1 mutant. In the mutant, the iron ac-
cumulations are visualized as electron-dense aggregates within mito-
chondria. Bars represent 1 mm.
examination of the yeast model, may be relevant to the
pathogenesis of FA. Hsp70 proteins are required, to en-
sure correct folding of a large number of proteins. Ssq1p
may be involved in the correct folding of a subset of
mitochondrial proteins. Thus, the loss of Ssq1p could
lead to toxic protein aggregates similar to those observed
in other neurodegenerative diseases, such as Huntington
and Parkinson diseases. Electron micrographs of the
ssq1 yeast mutant show massive electron-dense accu-
mulations. These dense bodies may also contain aggre-
gated proteins that damage the mitochondria and the
cell (fig. 1).
Another mechanism of cellular pathology could result
from damage to the mtDNA. Yeast lacking Yfh1p or
Ssq1p show evidence of mtDNA damage. The mecha-
nisms by which this damage is effected remain to be
determined. Increased oxidative stress resulting from ex-
cess iron might generate point mutations in the mtDNA
(Babcock et al. 1997). Alternatively, mtDNA instability
might result from decrease in a critical protein required
for transcription or translation of the mtDNA. Hsp70
proteins are required for phage head replication (DnaK)
and mtDNA replication in trypanosomes (Engman et al.
1989). In humans, various mutations in the mtDNA,
frequently present in the heteroplasmic state, have been
linked to neurodegenerative diseases. For example, an
A to G point mutation in the mitochondrial tRNAlys
causes myoclonic epilepsy and ragged red fiber syndrome
(Chomyn 1998). Individuals with this disorder have
symptoms of epilepsy and ataxia, with skeletal muscle
myopathy. mtDNA damage has not yet been assessed in
the affected tissues of patients with FA.
Human Diseases Revisited
The homology (and analogy) between the yeast YFH1
and human FRDA1 calls attention to the cellular ab-
normalities in FA. However, the disease affects some cells
and not others, even though frataxin is ubiquitously ex-
pressed. The basis for this tissue specificity of the disease
is not clear. The study of another yeast gene may shed
light on this question. ATM1 was cloned on the basis
of its homology with the ATP binding cassette family of
transporters. Deletion of the gene leads to mtDNA dam-
age, iron accumulation in mitochondria, and mitochon-
drial iron protein deficiency (Kispal et al. 1997). Thus,
the phenotypes resemble those of the yfh1 and ssq1mu-
tants. However, the human homologue of this gene re-
cently was cloned and was found to map to Xq13, a
region that has been linked to an inherited human dis-
ease called “X-linked sideroblastic anemia with ataxia”
(Allikmets et al. 1998; Shimada et al. 1998). This disease
is characterized by spinocerebellar ataxia, but patients
also manifest a mild sideroblastic anemia. The presence
of ringed sideroblasts is the hallmark of iron accumu-
lation within mitochondria of red-cell precursors and
has not been described in patients with FA.
FA was a clinical diagnosis prior to the cloning of the
gene. The spectrum of disease must be reevaluated, now
that individuals can be assessed for the presence of mu-
tations in FRDA1. The question arises whether variants
of FA that result from mutations in other genes will be
identified. A number of ataxia variants or phenocopies
of FA have been recognized. Although the majority of
these have been linked to FRDA1, some have not. Ataxia
with isolated vitamin E deficiency (AVED) is an auto-
somal recessive neurodegenerative disorder with a phe-
notype that closely resembles that of FA. Yet despite the
similar symptoms, AVED is attributed to frameshift or
missense mutations in the gene encoding the a-tocoph-
erol transfer protein on chromosome 8 (Ouahchi et al.
1995). The biochemical link between vitamin E defi-
ciency and iron is not entirely clear, although vitamin E
is a potent antioxidant and might protect against the
oxidative stress from iron overload.
Correct folding of proteins into their native state is
critical for their proper functioning, so diseases that re-
sult from abnormalities in chaperone function are likely
to exist. Ssc1p and Hsp60 are essential chaperone pro-
teins of yeast mitochondria. These proteins are highly
conserved with humans, and thus mutant alleles might
be implicated in disease causation. To date, only a few
reports have associated mitochondrial chaperones with
disease pathology. Mitochondria from two unrelated
girls, one of whom died 2 d after birth and the other at
age 4.5 years, were noted to have markedly reduced
levels of mitochondrial Hsp60 (Briones et al. 1997). The
morphology of the mitochondria was characterized by
disruptions of the inner membranes and an absence of
cristae. At the biochemical level, activities of some of
the tricarboxylic enzymes from cultured fibroblasts were
substantially lower than activities in controls, although
the Fe-S enzyme aconitase was not assayed. A Spanish
family with two members who exhibit the classic symp-
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toms of FA, in whom the disease does not segregate with
FRDA1, was recently reported by Smeyers et al. (1996).
The defective gene in this family might represent another
complementation group for FA, and a human homo-
logue of SSQ1 might be considered as a candidate gene.
To date, a human homologue of SSQ1 has not been
identified.
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